
Current Price | $4.33 | Mkt Cap | $473.4M |
---|---|---|---|
Open | $4.55 | P/E Ratio | -5.82 |
Prev. Close | $4.33 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $4.31 - $4.55 | Volume | 4,733,710 |
52-Wk Range | $2.52 - $8.52 | Avg. Daily Vol. | 3,721,653 |
Current Price | $4.33 | Mkt Cap | $473.4M |
---|---|---|---|
Open | $4.55 | P/E Ratio | -5.82 |
Prev. Close | $4.33 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $4.31 - $4.55 | Volume | 4,733,710 |
52-Wk Range | $2.52 - $8.52 | Avg. Daily Vol. | 3,721,653 |
The best Bull and Bear pitches based on recency and number of recommendations.
From Fidelity or Zacks December 2021:Revenue Growth (Last 5 Years) = 77.9%Revenue % Change (Last Qrtr VS. Same Qrtr Prior Year) = 17.7%Price/Sales (TTM) = 14.2Re-establishing this position at a lower price.
Weak pipeline, continued difficulty with commercialization, recently lost 100% of its C-suite, ongoing litigation, and more.
Read the most recent pitches from players about BLUE.
Recs
From Fidelity or Zacks December 2021:
Revenue Growth (Last 5 Years) = 77.9%
Revenue % Change (Last Qrtr VS. Same Qrtr Prior Year) = 17.7%
Price/Sales (TTM) = 14.2
Re-establishing this position at a lower price.
Recs
Gene therapies will be a huge growth sector in health care in the next decade.
Recs
Weak pipeline, continued difficulty with commercialization, recently lost 100% of its C-suite, ongoing litigation, and more.
Find the members with the highest scoring picks in BLUE.
DoubleBagel (< 20) Score: +669.10
The Score Leader is the player with the highest score across all their picks in BLUE.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
secohen11 | < 20 | 7/2/2013 |
![]() |
1Y | $26.20 | -83.47% | +183.39% | +266.86 | 0 Comment | |
saab93boi | < 20 | 6/19/2013 |
![]() |
5Y | $25.68 | -83.14% | +177.72% | +260.86 | 0 Comment | |
rwpaules | 70.30 | 6/19/2013 |
![]() |
3Y | $25.09 | -82.74% | +175.92% | +258.67 | 0 Comment | |
biotechf | 45.48 | 1/22/2016 |
![]() |
3M | $44.44 | -90.26% | +141.18% | +231.43 | 0 Comment | |
MotleyFolJohn | < 20 | 2/2/2015 |
![]() |
1Y | $93.98 | -95.39% | +128.67% | +224.06 | 1 Comment | |
pro64grammer | 24.38 | 12/9/2014 |
![]() |
5Y | $79.58 | -94.56% | +123.07% | +217.63 | 0 Comment | |
cthomas1017 | 98.06 | 7/16/2014 |
![]() |
5Y | $31.85 | -86.41% | +131.08% | +217.49 | 0 Comment | |
![]() |
CommodityBuyer | < 20 | 7/10/2015 |
![]() |
5Y | $160.69 | -97.31% | +120.16% | +217.46 | 0 Comment |
3rdChanceTom | 86.34 | 3/11/2016 |
![]() |
5Y | $45.77 | -90.54% | +126.87% | +217.41 | 0 Comment | |
coptermech66 | < 20 | 10/29/2015 |
![]() |
3Y | $79.54 | -94.56% | +118.67% | +213.22 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.